Sarbanes-Oxley

The Sarbanes-Oxley Act, chiefly aimed at resurrecting investors' trust in the public markets, has prompted a fierce debate about its many unintended side effects and their impact on the private equity industry. To find out what exactly the issues are, Private Equity International consulted two legal practitioners. In these pages, Franci J. Blassberg of Debevoise & Plimpton and Prakash Metha of Akin Gump Strauss Hauer & Feld get to grips with the new rules and the ways in which they are going to affect the private equity business.